Company Filing History:
1 out of 5 
1 out of 1 Years Active: 2011-2016
Title: Jiankun Qie: Innovator in Pharmaceutical Sciences
Introduction
Jiankun Qie is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug formulations. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments for various medical conditions.
Latest Patents
Jiankun Qie's latest patents include groundbreaking inventions such as site-specific PEGylated linear salmon calcitonin analogues. This invention relates to the preparation of these analogs and their use in treating diseases associated with bone metabolism, such as osteoporosis. Another notable patent is the polyethylene glycol modifications of thymosin alpha-1, which addresses immune deficiency and hypoimmunity, with applications in treating conditions like hepatitis B, hepatitis C, and AIDS.
Career Highlights
Throughout his career, Jiankun Qie has worked at esteemed institutions, including the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences in China. His research has significantly impacted the pharmaceutical industry, leading to advancements in drug development and therapeutic applications.
Collaborations
Jiankun Qie has collaborated with notable colleagues, including Keliang Liu and Zhixia Yang. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Jiankun Qie's contributions to pharmaceutical sciences exemplify his dedication to improving healthcare through innovative drug formulations. His patents reflect a commitment to addressing critical medical challenges, making him a noteworthy figure in the field.